Covid Vaccine Price

Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday

The Supreme Court on Friday said it cannot just cast doubt on the country's Covid vaccination programme at this crucial stage and cannot afford the price of laxity of not vaccinating people.

Zydus Cadila's ZyCov-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above

IMF Chief Economist Gita Gopinath: Core inflation is high in India and this needs to be looked into

India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.

Union Minister of State for Petroleum and Natural Gas Rameswar Teli has compared the rising price of petrol with that of packaged mineral water and said that the price of such water is more.

The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.

Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.

Google Search, Maps, and Assistant in India will now show additional information about vaccine availability and appointments. They will help people get information like availability of slots, expected pricing, information on doses, and more.

There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.

Cadila Healthcare's total revenue from operations in the first quarter of the current fiscal stood at Rs 4,025.4 crore, compared to Rs 3,514.6 crore in the year-ago period

Oil prices edged higher on Tuesday as investors bet that tight supply and rising vaccination rates will help to offset any impact on demand from surging COVID-19 cases worldwide.

The Covovax shot developed by American vaccine-maker Novavax would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, company's CEO Stanley Erck said in an exclusive interview.

Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.

Days after Centre announced a price cap for administration of COVID-19 vaccines in private hospitals, Delhi's first drive-through vaccination centre has decided to shut down its facility from today, stating that the operation has become "unviable".

Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday

The Supreme Court on Friday said it cannot just cast doubt on the country's Covid vaccination programme at this crucial stage and cannot afford the price of laxity of not vaccinating people.

Zydus Cadila's ZyCov-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above

IMF Chief Economist Gita Gopinath: Core inflation is high in India and this needs to be looked into

India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.

Union Minister of State for Petroleum and Natural Gas Rameswar Teli has compared the rising price of petrol with that of packaged mineral water and said that the price of such water is more.

The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.

Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.

Google Search, Maps, and Assistant in India will now show additional information about vaccine availability and appointments. They will help people get information like availability of slots, expected pricing, information on doses, and more.

There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.

Cadila Healthcare's total revenue from operations in the first quarter of the current fiscal stood at Rs 4,025.4 crore, compared to Rs 3,514.6 crore in the year-ago period

Oil prices edged higher on Tuesday as investors bet that tight supply and rising vaccination rates will help to offset any impact on demand from surging COVID-19 cases worldwide.

The Covovax shot developed by American vaccine-maker Novavax would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, company's CEO Stanley Erck said in an exclusive interview.

Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.

Days after Centre announced a price cap for administration of COVID-19 vaccines in private hospitals, Delhi's first drive-through vaccination centre has decided to shut down its facility from today, stating that the operation has become "unviable".